BDBM503515 N-{2-[(4-{N-[(7S)-4- fluorobicyclo[4.2.0]octa-1,3,5-trien- 7-yl]-N'-hydroxycarbamimidoyl}- 1,2,5-oxadiazol-3-yl)oxy]ethyl}-1H- 1,2,4-triazole-3-carboxamide::US11034661, Example 22

SMILES O\N=C(/N[C@H]1Cc2ccc(F)cc12)c1nonc1OCCNC(=O)c1nc[nH]n1

InChI Key InChIKey=HUXSYAJRNPQUQS-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 503515   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM503515(N-{2-[(4-{N-[(7S)-4- fluorobicyclo[4.2.0]octa-1,3...)
Affinity DataIC50: 264nMAssay Description:HIS-tagged IDO1 protein was recombinantly expressed in Escherichia coli using ZYP5052 autoinduction media supplemented with 500 μM delta aminole...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/5/2021
Entry Details
US Patent